InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

DNTH Stock Earnings: Dianthus Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

DNTH stock results show that Dianthus Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

FRD Stock Earnings: Friedman Industries Reported Results for Q1 2025

By InvestorPlace Earnings

Friedman Industries just reported results for the first quarter of 2025.

BHVN Stock Earnings: Biohaven Misses EPS for Q2 2024

By InvestorPlace Earnings

BHVN stock results show that Biohaven missed analyst estimates for earnings per share the second quarter of 2024.

Load More